Cargando…

The ratio of urinary sodium and potassium and chronic kidney disease progression: Results from the KoreaN Cohort Study for Outcomes in Patients with Chronic Kidney Disease (KNOW-CKD)

The Na/K ratio in urine stands for the dietary of sodium and potassium intake in patients with chronic kidney disease remains unclear for the renal progression. We aimed to determine the risk of progression of chronic kidney disease based on the Na/K ratio in a 24-hour urine collection. We determine...

Descripción completa

Detalles Bibliográficos
Autores principales: Koo, Hoseok, Hwang, Subin, Kim, Tae Hee, Kang, Sun Woo, Oh, Kook-Hwan, Ahn, Curie, Kim, Yeong Hoon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6221621/
https://www.ncbi.nlm.nih.gov/pubmed/30383635
http://dx.doi.org/10.1097/MD.0000000000012820
_version_ 1783369052763193344
author Koo, Hoseok
Hwang, Subin
Kim, Tae Hee
Kang, Sun Woo
Oh, Kook-Hwan
Ahn, Curie
Kim, Yeong Hoon
author_facet Koo, Hoseok
Hwang, Subin
Kim, Tae Hee
Kang, Sun Woo
Oh, Kook-Hwan
Ahn, Curie
Kim, Yeong Hoon
author_sort Koo, Hoseok
collection PubMed
description The Na/K ratio in urine stands for the dietary of sodium and potassium intake in patients with chronic kidney disease remains unclear for the renal progression. We aimed to determine the risk of progression of chronic kidney disease based on the Na/K ratio in a 24-hour urine collection. We determined the association between the progression of renal disease and 24-hour urinary sodium and potassium (Na/K) ratios in 2238 patients over a 5-year timespan using data obtained from the KoreaN cohort study for Outcomes in patients With Chronic Kidney Disease (KNOW-CKD). Renal events were defined as a 50% decrease in the glomerular filtration rate (GFR) below baseline, or the onset of end-stage renal disease (ESRD). Patients were divided into 4 groups based on the quartile range of the 24-hour urinary sodium and potassium ratio. We analyzed those variables in the 4 groups. Multiple logistic regression analyses were performed using the data of 1001 patients to identify the independent factors associated with renal events. Age and male sex accounted for the greatest number of patients in the group with the highest values (group 4) of the 24-hour urinary Na/K ratio (≥3.85). There was no difference in the prevalence of hypertension or diabetes mellitus, the ratio of use of antihypertensive drugs, blood pressures, or estimated GFRs. In the group with the highest urinary Na/K ratio, the 24-hour urinary Na concentration mean ± standard deviation was 188.7 ± 70.6 mmol and that of urinary K was 39.9 ± 16.1 mmol. The urinary protein excretion was highest in the group with the highest urinary Na/K ratio. In the logistic regression analysis, the effect on renal events increased with increasing urinary Na/K ratios. After adjusting for other factors, the risk of renal events was 2.48 (95% confidence interval (CI) 1.30–4.90) in group 3, and 3.75 (95% CI: 1.35–11.27) in group 4. In the Kaplan–Meier analysis, the higher the urinary Na/K ratio, the higher the rate of CKD progression. Based on our analyses, we concluded that the higher the urinary Na/K ratio, the greater the risk of CKD progression.
format Online
Article
Text
id pubmed-6221621
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Wolters Kluwer Health
record_format MEDLINE/PubMed
spelling pubmed-62216212018-12-04 The ratio of urinary sodium and potassium and chronic kidney disease progression: Results from the KoreaN Cohort Study for Outcomes in Patients with Chronic Kidney Disease (KNOW-CKD) Koo, Hoseok Hwang, Subin Kim, Tae Hee Kang, Sun Woo Oh, Kook-Hwan Ahn, Curie Kim, Yeong Hoon Medicine (Baltimore) Research Article The Na/K ratio in urine stands for the dietary of sodium and potassium intake in patients with chronic kidney disease remains unclear for the renal progression. We aimed to determine the risk of progression of chronic kidney disease based on the Na/K ratio in a 24-hour urine collection. We determined the association between the progression of renal disease and 24-hour urinary sodium and potassium (Na/K) ratios in 2238 patients over a 5-year timespan using data obtained from the KoreaN cohort study for Outcomes in patients With Chronic Kidney Disease (KNOW-CKD). Renal events were defined as a 50% decrease in the glomerular filtration rate (GFR) below baseline, or the onset of end-stage renal disease (ESRD). Patients were divided into 4 groups based on the quartile range of the 24-hour urinary sodium and potassium ratio. We analyzed those variables in the 4 groups. Multiple logistic regression analyses were performed using the data of 1001 patients to identify the independent factors associated with renal events. Age and male sex accounted for the greatest number of patients in the group with the highest values (group 4) of the 24-hour urinary Na/K ratio (≥3.85). There was no difference in the prevalence of hypertension or diabetes mellitus, the ratio of use of antihypertensive drugs, blood pressures, or estimated GFRs. In the group with the highest urinary Na/K ratio, the 24-hour urinary Na concentration mean ± standard deviation was 188.7 ± 70.6 mmol and that of urinary K was 39.9 ± 16.1 mmol. The urinary protein excretion was highest in the group with the highest urinary Na/K ratio. In the logistic regression analysis, the effect on renal events increased with increasing urinary Na/K ratios. After adjusting for other factors, the risk of renal events was 2.48 (95% confidence interval (CI) 1.30–4.90) in group 3, and 3.75 (95% CI: 1.35–11.27) in group 4. In the Kaplan–Meier analysis, the higher the urinary Na/K ratio, the higher the rate of CKD progression. Based on our analyses, we concluded that the higher the urinary Na/K ratio, the greater the risk of CKD progression. Wolters Kluwer Health 2018-11-02 /pmc/articles/PMC6221621/ /pubmed/30383635 http://dx.doi.org/10.1097/MD.0000000000012820 Text en Copyright © 2018 the Author(s). Published by Wolters Kluwer Health, Inc. http://creativecommons.org/licenses/by/4.0 This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/4.0
spellingShingle Research Article
Koo, Hoseok
Hwang, Subin
Kim, Tae Hee
Kang, Sun Woo
Oh, Kook-Hwan
Ahn, Curie
Kim, Yeong Hoon
The ratio of urinary sodium and potassium and chronic kidney disease progression: Results from the KoreaN Cohort Study for Outcomes in Patients with Chronic Kidney Disease (KNOW-CKD)
title The ratio of urinary sodium and potassium and chronic kidney disease progression: Results from the KoreaN Cohort Study for Outcomes in Patients with Chronic Kidney Disease (KNOW-CKD)
title_full The ratio of urinary sodium and potassium and chronic kidney disease progression: Results from the KoreaN Cohort Study for Outcomes in Patients with Chronic Kidney Disease (KNOW-CKD)
title_fullStr The ratio of urinary sodium and potassium and chronic kidney disease progression: Results from the KoreaN Cohort Study for Outcomes in Patients with Chronic Kidney Disease (KNOW-CKD)
title_full_unstemmed The ratio of urinary sodium and potassium and chronic kidney disease progression: Results from the KoreaN Cohort Study for Outcomes in Patients with Chronic Kidney Disease (KNOW-CKD)
title_short The ratio of urinary sodium and potassium and chronic kidney disease progression: Results from the KoreaN Cohort Study for Outcomes in Patients with Chronic Kidney Disease (KNOW-CKD)
title_sort ratio of urinary sodium and potassium and chronic kidney disease progression: results from the korean cohort study for outcomes in patients with chronic kidney disease (know-ckd)
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6221621/
https://www.ncbi.nlm.nih.gov/pubmed/30383635
http://dx.doi.org/10.1097/MD.0000000000012820
work_keys_str_mv AT koohoseok theratioofurinarysodiumandpotassiumandchronickidneydiseaseprogressionresultsfromthekoreancohortstudyforoutcomesinpatientswithchronickidneydiseaseknowckd
AT hwangsubin theratioofurinarysodiumandpotassiumandchronickidneydiseaseprogressionresultsfromthekoreancohortstudyforoutcomesinpatientswithchronickidneydiseaseknowckd
AT kimtaehee theratioofurinarysodiumandpotassiumandchronickidneydiseaseprogressionresultsfromthekoreancohortstudyforoutcomesinpatientswithchronickidneydiseaseknowckd
AT kangsunwoo theratioofurinarysodiumandpotassiumandchronickidneydiseaseprogressionresultsfromthekoreancohortstudyforoutcomesinpatientswithchronickidneydiseaseknowckd
AT ohkookhwan theratioofurinarysodiumandpotassiumandchronickidneydiseaseprogressionresultsfromthekoreancohortstudyforoutcomesinpatientswithchronickidneydiseaseknowckd
AT ahncurie theratioofurinarysodiumandpotassiumandchronickidneydiseaseprogressionresultsfromthekoreancohortstudyforoutcomesinpatientswithchronickidneydiseaseknowckd
AT kimyeonghoon theratioofurinarysodiumandpotassiumandchronickidneydiseaseprogressionresultsfromthekoreancohortstudyforoutcomesinpatientswithchronickidneydiseaseknowckd
AT koohoseok ratioofurinarysodiumandpotassiumandchronickidneydiseaseprogressionresultsfromthekoreancohortstudyforoutcomesinpatientswithchronickidneydiseaseknowckd
AT hwangsubin ratioofurinarysodiumandpotassiumandchronickidneydiseaseprogressionresultsfromthekoreancohortstudyforoutcomesinpatientswithchronickidneydiseaseknowckd
AT kimtaehee ratioofurinarysodiumandpotassiumandchronickidneydiseaseprogressionresultsfromthekoreancohortstudyforoutcomesinpatientswithchronickidneydiseaseknowckd
AT kangsunwoo ratioofurinarysodiumandpotassiumandchronickidneydiseaseprogressionresultsfromthekoreancohortstudyforoutcomesinpatientswithchronickidneydiseaseknowckd
AT ohkookhwan ratioofurinarysodiumandpotassiumandchronickidneydiseaseprogressionresultsfromthekoreancohortstudyforoutcomesinpatientswithchronickidneydiseaseknowckd
AT ahncurie ratioofurinarysodiumandpotassiumandchronickidneydiseaseprogressionresultsfromthekoreancohortstudyforoutcomesinpatientswithchronickidneydiseaseknowckd
AT kimyeonghoon ratioofurinarysodiumandpotassiumandchronickidneydiseaseprogressionresultsfromthekoreancohortstudyforoutcomesinpatientswithchronickidneydiseaseknowckd